Oncology Times - OncTimes Talk

Unknown

4,3 (3)
SCIENCES
TOUTES LES 2 SEMAINES

OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.

25 JANV.

KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma

Oncology Times - OncTimes Talk

8 min
13 JANV.

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Oncology Times - OncTimes Talk

16 min
10 JANV.

Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development

Oncology Times - OncTimes Talk

9 min
10 JANV.

Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma

Oncology Times - OncTimes Talk

7 min
10 JANV.

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Oncology Times - OncTimes Talk

8 min
10 JANV.

Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer

Oncology Times - OncTimes Talk

7 min
31/12/2024

The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front

Oncology Times - OncTimes Talk

14 min
25/12/2024

Digital Twin Brings AI Power to Individualize Cancer Management

Oncology Times - OncTimes Talk

12 min

Tout afficher (185)

4,3

sur 5

3 notes

OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.

Création

Unknown
Années d’activité

2012 - 2025
Épisodes

185
Classification

Tous publics
Site web de l’émission

Oncology Times - OncTimes Talk

Carrière

Carrière

Chaque semaine
Forme et santé

Forme et santé

Toutes les 2 semaines

Oncology Times - OncTimes Talk

KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development

Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer

The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front

Digital Twin Brings AI Power to Individualize Cancer Management

Notes et avis

À propos

Informations

Vous aimeriez peut‑être aussi

Oncology Times - OncTimes Talk

Épisodes

KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development

Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer

The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front

Digital Twin Brings AI Power to Individualize Cancer Management

Notes et avis

À propos

Informations

Vous aimeriez peut‑être aussi